Financial reports
ARS
2023 FY
Annual report to shareholders
5 Apr 24
10-K
2023 FY
Annual report
7 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
7 Apr 23
10-K
2022 FY
Annual report
14 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
Current reports
8-K
RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
7 Mar 24
8-K
Regulation FD Disclosure
22 Feb 24
8-K
Other Events
20 Feb 24
8-K
RAPT Therapeutics Reports Third Quarter 2023 Financial Results
13 Nov 23
8-K
Regulation FD Disclosure
3 Nov 23
8-K
Other Events
11 Aug 23
8-K
RAPT Therapeutics Reports Second Quarter 2023 Financial Results
11 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
26 May 23
8-K
RAPT Therapeutics Reports First Quarter 2023 Financial Results
11 May 23
8-K
RAPT Therapeutics Reports Fourth Quarter And Year End Financial Results
14 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
7 Mar 24
424B5
Prospectus supplement for primary offering
17 Aug 23
S-3
Shelf registration
11 Aug 23
S-8
Registration of securities for employees
14 Mar 23
424B5
Prospectus supplement for primary offering
18 Nov 22
424B5
Prospectus supplement for primary offering
17 Nov 22
424B3
Prospectus supplement
29 Jun 22
S-3
Shelf registration
24 Jun 22
D
$50M in options / securities to be acquired, sold $50M, 1 investor
3 Jun 22
S-8
Registration of securities for employees
10 Mar 22
Proxies
DEFA14A
Additional proxy soliciting materials
5 Apr 24
DEF 14A
Definitive proxy
5 Apr 24
DEFA14A
Additional proxy soliciting materials
15 May 23
DEFA14A
Additional proxy soliciting materials
7 Apr 23
DEF 14A
Definitive proxy
7 Apr 23
DEFA14A
Additional proxy soliciting materials
11 Apr 22
DEF 14A
Definitive proxy
11 Apr 22
DEFA14A
Additional proxy soliciting materials
15 Apr 21
DEF 14A
Definitive proxy
15 Apr 21
DEFA14A
Additional proxy soliciting materials
29 Apr 20
Other
EFFECT
Notice of effectiveness
18 Aug 23
CORRESP
Correspondence with SEC
15 Aug 23
UPLOAD
Letter from SEC
14 Aug 23
EFFECT
Notice of effectiveness
30 Jun 22
CORRESP
Correspondence with SEC
27 Jun 22
UPLOAD
Letter from SEC
27 Jun 22
EFFECT
Notice of effectiveness
17 Nov 20
CORRESP
Correspondence with SEC
10 Nov 20
UPLOAD
Letter from SEC
6 Nov 20
EFFECT
Notice of effectiveness
7 Feb 20
Ownership
4
Wendye Robbins
1 Apr 24
4
MARY ANN GRAY
1 Apr 24
4
WILLIAM JL RIEFLIN
1 Apr 24
SC 13G/A
PERCEPTIVE ADVISORS LLC
14 Feb 24
SC 13G/A
Redmile Group, LLC
14 Feb 24
SC 13G/A
PRICE T ROWE ASSOCIATES INC /MD/
14 Feb 24
SC 13G/A
Deep Track Capital, LP
14 Feb 24
SC 13G
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
4
WILLIAM HO
1 Feb 24